PubMed

Muscle microvascular dysfunction in central obesity is related to muscle insulin insensitivity but is not reversed by high-dose statin treatment.

Clough GF, Turzyniecka M, Walter L, Krentz AJ, Wild SH, Chipperfield AJ, Gamble J, Byrne CD.

Diabetes. 2009 May;58(5):1185-91. Epub 2009 Feb 10.PMID: 19208914 [PubMed - indexed for MEDLINE]Related articlesFree article

Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial.

Ross R, Dagnone D, Jones PJ, Smith H, Paddags A, Hudson R, Janssen I.

Ann Intern Med. 2000 Jul 18;133(2):92-103.PMID: 10896648 [PubMed - indexed for MEDLINE]Related articlesFree article

Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk.

Forst T, Wilhelm B, Pfützner A, Fuchs W, Lehmann U, Schaper F, Weber M, Müller J, Konrad T, Hanefeld M.

Diab Vasc Dis Res. 2008 Nov;5(4):298-303.PMID: 18958840 [PubMed - indexed for MEDLINE]Related articles

Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity.

Chan DC, Watts GF, Mori TA, Barrett PH, Beilin LJ, Redgrave TG.

Eur J Clin Invest. 2002 Jun;32(6):429-36.PMID: 12059988 [PubMed - indexed for MEDLINE]Related articles

A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.

Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.

Clin Ther. 2008 Jun;30(6):1089-101.PMID: 18640465 [PubMed - indexed for MEDLINE]Related articles

High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial.

Päivä H, Thelen KM, Van Coster R, Smet J, De Paepe B, Mattila KM, Laakso J, Lehtimäki T, von Bergmann K, Lütjohann D, Laaksonen R.

Clin Pharmacol Ther. 2005 Jul;78(1):60-8.PMID: 16003294 [PubMed - indexed for MEDLINE]Related articles

Effect of atorvastatin (10 mg/day) on glucose metabolism in patients with the metabolic syndrome.

Huptas S, Geiss HC, Otto C, Parhofer KG.

Am J Cardiol. 2006 Jul 1;98(1):66-9. Epub 2006 May 4.PMID: 16784923 [PubMed - indexed for MEDLINE]Related articles

Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patients.

Fogari R, Preti P, Zoppi A, Lazzari P, Corradi L, Fogari E, Ciccarelli L, Derosa G.

Eur J Clin Pharmacol. 2006 Oct;62(10):817-22. Epub 2006 Aug 2.PMID: 16896785 [PubMed - indexed for MEDLINE]Related articles

Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.

Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J.

Am J Geriatr Pharmacother. 2005 Dec;3(4):218-28.PMID: 16503317 [PubMed - indexed for MEDLINE]Related articles

Effect of low doses of atorvastatin on adiponectin, glucose homeostasis, and clinical inflammatory markers in kidney transplant recipients.

Bayés B, Granada ML, Lauzurica R, Pastor MC, Navarro M, Bonet J, Llopis MA, Romero R.

Transplant Proc. 2005 Nov;37(9):3808-12.PMID: 16386546 [PubMed - indexed for MEDLINE]Related articles

Short-term effect of atorvastatin on endothelial function in healthy offspring of parents with type 2 diabetes mellitus.

Amudha K, Choy AM, Mustafa MR, Lang CC.

Cardiovasc Ther. 2008 Winter;26(4):253-61.PMID: 19035876 [PubMed - indexed for MEDLINE]Related articles

Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia.

Chan DC, Watts GF, Barrett PH, Beilin LJ, Redgrave TG, Mori TA.

Diabetes. 2002 Aug;51(8):2377-86.PMID: 12145148 [PubMed - indexed for MEDLINE]Related articlesFree article

Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.

Nam SY, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB.

Int J Obes Relat Metab Disord. 2001 Aug;25(8):1101-7.PMID: 11477493 [PubMed - indexed for MEDLINE]Related articlesFree article

Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle.

Clerk LH, Vincent MA, Jahn LA, Liu Z, Lindner JR, Barrett EJ.

Diabetes. 2006 May;55(5):1436-42.PMID: 16644702 [PubMed - indexed for MEDLINE]Related articlesFree article

Changes in aerobic capacity and visceral fat but not myocyte lipid levels predict increased insulin action after exercise in overweight and obese men.

Gan SK, Kriketos AD, Ellis BA, Thompson CH, Kraegen EW, Chisholm DJ.

Diabetes Care. 2003 Jun;26(6):1706-13.PMID: 12766098 [PubMed - indexed for MEDLINE]Related articlesFree article

A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD.

Dogra G, Irish A, Chan D, Watts G.

Am J Kidney Dis. 2007 Jun;49(6):776-85.PMID: 17533020 [PubMed - indexed for MEDLINE]Related articles

What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?

Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA, Poehlman ET.

J Clin Endocrinol Metab. 2001 Mar;86(3):1020-5.PMID: 11238480 [PubMed - indexed for MEDLINE]Related articlesFree article

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.

Nissen SE, Tuzcu EM, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J, Orazem J, Magorien RD, O'Shaughnessy C, Ganz P; Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Investigators.

N Engl J Med. 2005 Jan 6;352(1):29-38.PMID: 15635110 [PubMed - indexed for MEDLINE]Related articlesFree article

Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure.

Johannsson G, Mårin P, Lönn L, Ottosson M, Stenlöf K, Björntorp P, Sjöström L, Bengtsson BA.

J Clin Endocrinol Metab. 1997 Mar;82(3):727-34.PMID: 9062473 [PubMed - indexed for MEDLINE]Related articlesFree article

Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.

Dogra GK, Watts GF, Chan DC, Stanton K.

Diabet Med. 2005 Mar;22(3):239-42.PMID: 15717868 [PubMed - indexed for MEDLINE]Related articles